Clo­vis says it needs mon­ey af­ter re­verse split vot­ed down; Cin­Cor touts PhII da­ta for hy­per­ten­sion drug

Clo­vis On­col­o­gy needs a se­ri­ous leg up af­ter post­ing a $71.3 mil­lion net loss in Q2.

Ac­cord­ing to the com­pa­ny’s Q2 re­port, based on its …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.